The 36-month beta value for VANI is at 3.15. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for VANI is 30.19M, and currently, shorts hold a 2.50% of that float. The average trading volume for VANI on November 14, 2024 was 72.93K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
VANI) stock’s latest price update
Vivani Medical Inc (NASDAQ: VANI) has experienced a rise in its stock price by 11.20 compared to its previous closing price of 1.25. However, the company has seen a gain of 10.32% in its stock price over the last five trading days. businesswire.com reported 2024-09-26 that ALAMEDA, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, biopharmaceutical company developing novel, ultra long-acting drug implants, today announced that the Bellberry Human Research Ethics Committee (“HREC”) has approved and the Therapeutic Goods Administration (“TGA”) in Australia has formally acknowledged a first in human clinical trial of the Company’s miniature, subdermal GLP-1 (exenatide) implant in obese and overweight subjects. T.
VANI’s Market Performance
Vivani Medical Inc (VANI) has experienced a 10.32% rise in stock performance for the past week, with a 19.83% rise in the past month, and a 9.45% rise in the past quarter. The volatility ratio for the week is 5.99%, and the volatility levels for the past 30 days are at 4.49% for VANI. The simple moving average for the past 20 days is 8.38% for VANI’s stock, with a -6.24% simple moving average for the past 200 days.
VANI Trading at 13.48% from the 50-Day Moving Average
After a stumble in the market that brought VANI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.18% of loss for the given period.
Volatility was left at 4.49%, however, over the last 30 days, the volatility rate increased by 5.99%, as shares surge +12.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.88% upper at present.
During the last 5 trading sessions, VANI rose by +10.32%, which changed the moving average for the period of 200-days by +34.95% in comparison to the 20-day moving average, which settled at $1.2825. In addition, Vivani Medical Inc saw 36.27% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VANI starting from Williams Gregg, who purchase 3,968,253 shares at the price of $1.26 back on Nov 08 ’24. After this action, Williams Gregg now owns 4,695,861 shares of Vivani Medical Inc, valued at $4,999,999 using the latest closing price.
Dwyer Donald, the Chief Business Officer of Vivani Medical Inc, purchase 1,000 shares at $1.14 during a trade that took place back on Oct 01 ’24, which means that Dwyer Donald is holding 48,500 shares at $1,140 based on the most recent closing price.
Stock Fundamentals for VANI
Current profitability levels for the company are sitting at:
- -47.17 for the present operating margin
- 0.43 for the gross margin
The net margin for Vivani Medical Inc stands at -45.29. The total capital return value is set at -0.67. Equity return is now at value -86.10, with -44.89 for asset returns.
Based on Vivani Medical Inc (VANI), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at -1.15. The debt to equity ratio resting at 1.07. The interest coverage ratio of the stock is -86.34.
Currently, EBITDA for the company is -26.61 million with net debt to EBITDA at -0.0. When we switch over and look at the enterprise to sales, we see a ratio of 148.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.55.
Conclusion
In conclusion, Vivani Medical Inc (VANI) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
